KCNJ11 and diabetes mellitus: SUR1-KIR6.2 mediates potassium efflux and hyperpolarizes cells; channel blockade by GLI stimulates insulin release, thus leading to its utility in the treatment of diabetes mellitus [46,47,48,49].